RMD logo

ResMed (RMD) Cash From Investing

Annual CFI

-$269.78 M
+$890.06 M+76.74%

30 June 2024

RMD Cash From Investing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFI

$2.15 M
+$48.66 M+104.61%

30 September 2024

RMD Quarterly CFI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFI

-$118.66 M
+$151.13 M+56.02%

30 September 2024

RMD TTM CFI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RMD Cash From Investing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+76.7%+101.4%+90.5%
3 y3 years-70.3%+105.1%+33.4%
5 y5 years+74.9%+106.5%+87.7%

RMD Cash From Investing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-70.3%+76.7%at high+100.2%at high+90.5%
5 y5 years-70.3%+76.7%at high+100.2%-4.3%+90.5%
alltimeall time-2093.1%+76.7%-93.7%+100.2%-360.1%+90.5%

ResMed Cash From Investing History

DateAnnualQuarterlyTTM
Sept 2024
-
$2.15 M(-104.6%)
-$118.66 M(-56.0%)
June 2024
-$269.78 M(-76.7%)
-$46.51 M(+40.3%)
-$269.78 M(-0.0%)
Mar 2024
-
-$33.15 M(-19.4%)
-$269.80 M(+1.9%)
Dec 2023
-
-$41.14 M(-72.4%)
-$264.75 M(-78.8%)
Sept 2023
-
-$148.98 M(+220.2%)
-$1.25 B(+7.8%)
June 2023
-$1.16 B(+404.5%)
-$46.52 M(+65.5%)
-$1.16 B(-0.7%)
Mar 2023
-
-$28.10 M(-97.3%)
-$1.17 B(-1.8%)
Dec 2022
-
-$1.03 B(+1645.4%)
-$1.19 B(+382.1%)
Sept 2022
-
-$58.81 M(+6.5%)
-$246.85 M(+7.4%)
June 2022
-$229.92 M(+45.1%)
-$55.24 M(+11.6%)
-$229.92 M(+3.2%)
Mar 2022
-
-$49.49 M(-40.6%)
-$222.75 M(-3.9%)
Dec 2021
-
-$83.31 M(+98.9%)
-$231.87 M(+30.1%)
Sept 2021
-
-$41.87 M(-12.9%)
-$178.23 M(+12.5%)
June 2021
-$158.46 M(-11.9%)
-$48.07 M(-18.0%)
-$158.46 M(+39.2%)
Mar 2021
-
-$58.62 M(+97.6%)
-$113.80 M(-26.5%)
Dec 2020
-
-$29.66 M(+34.2%)
-$154.79 M(-8.3%)
Sept 2020
-
-$22.11 M(+549.0%)
-$168.75 M(-6.2%)
June 2020
-$179.86 M(-83.3%)
-$3.41 M(-96.6%)
-$179.86 M(-18.4%)
Mar 2020
-
-$99.61 M(+128.4%)
-$220.34 M(-36.3%)
Dec 2019
-
-$43.62 M(+31.3%)
-$346.14 M(-64.0%)
Sept 2019
-
-$33.22 M(-24.3%)
-$960.74 M(-10.7%)
June 2019
-$1.08 B(+956.4%)
-$43.89 M(-80.5%)
-$1.08 B(+0.5%)
Mar 2019
-
-$225.41 M(-65.8%)
-$1.07 B(+23.8%)
Dec 2018
-
-$658.22 M(+344.2%)
-$864.56 M(+268.5%)
Sept 2018
-
-$148.19 M(+284.6%)
-$234.59 M(+130.4%)
June 2018
-$101.82 M(+24.3%)
-$38.53 M(+96.4%)
-$101.82 M(+7.7%)
Mar 2018
-
-$19.62 M(-30.6%)
-$94.58 M(+1.8%)
Dec 2017
-
-$28.25 M(+83.2%)
-$92.88 M(+10.4%)
Sept 2017
-
-$15.42 M(-50.7%)
-$84.14 M(+2.8%)
June 2017
-$81.89 M(-92.7%)
-$31.28 M(+74.6%)
-$81.89 M(-90.6%)
Mar 2017
-
-$17.92 M(-8.2%)
-$868.77 M(-7.0%)
Dec 2016
-
-$19.52 M(+48.2%)
-$934.58 M(-13.2%)
Sept 2016
-
-$13.17 M(-98.4%)
-$1.08 B(-4.4%)
June 2016
-$1.13 B(+686.8%)
-$818.16 M(+877.1%)
-$1.13 B(+240.0%)
Mar 2016
-
-$83.73 M(-48.0%)
-$331.07 M(+24.3%)
Dec 2015
-
-$161.11 M(+156.8%)
-$266.33 M(+62.2%)
Sept 2015
-
-$62.75 M(+167.3%)
-$164.22 M(+14.8%)
June 2015
-$143.07 M(+50.6%)
-$23.48 M(+23.6%)
-$143.07 M(+0.4%)
Mar 2015
-
-$19.00 M(-67.8%)
-$142.43 M(-2.9%)
Dec 2014
-
-$58.99 M(+41.8%)
-$146.63 M(+27.5%)
Sept 2014
-
-$41.60 M(+82.2%)
-$115.00 M(+21.1%)
June 2014
-$94.99 M(+21.8%)
-$22.84 M(-1.6%)
-$94.99 M(-3.7%)
Mar 2014
-
-$23.20 M(-15.2%)
-$98.64 M(+2.3%)
Dec 2013
-
-$27.36 M(+26.7%)
-$96.44 M(+14.0%)
Sept 2013
-
-$21.59 M(-18.5%)
-$84.61 M(+8.5%)
June 2013
-$78.00 M(-23.2%)
-$26.48 M(+26.1%)
-$78.00 M(+30.7%)
Mar 2013
-
-$21.00 M(+35.3%)
-$59.67 M(+34.2%)
Dec 2012
-
-$15.53 M(+3.6%)
-$44.47 M(-1.0%)
Sept 2012
-
-$14.98 M(+83.8%)
-$44.91 M(-55.8%)
June 2012
-$101.61 M(+32.8%)
-$8.15 M(+40.3%)
-$101.61 M(-6.4%)
Mar 2012
-
-$5.81 M(-63.6%)
-$108.60 M(-7.5%)
Dec 2011
-
-$15.97 M(-77.7%)
-$117.39 M(+0.1%)
Sept 2011
-
-$71.69 M(+373.6%)
-$117.29 M(+53.3%)
June 2011
-$76.51 M(+31.2%)
-$15.14 M(+3.7%)
-$76.51 M(+1.1%)
Mar 2011
-
-$14.60 M(-8.0%)
-$75.67 M(+7.4%)
Dec 2010
-
-$15.87 M(-48.7%)
-$70.48 M(-7.0%)
Sept 2010
-
-$30.91 M(+116.2%)
-$75.82 M(+30.0%)
June 2010
-$58.31 M
-$14.30 M(+52.0%)
-$58.31 M(-11.2%)
DateAnnualQuarterlyTTM
Mar 2010
-
-$9.41 M(-55.6%)
-$65.67 M(-16.8%)
Dec 2009
-
-$21.21 M(+58.3%)
-$78.90 M(-10.1%)
Sept 2009
-
-$13.40 M(-38.2%)
-$87.76 M(-19.7%)
June 2009
-$109.30 M(+188.7%)
-$21.66 M(-4.3%)
-$109.30 M(+6.6%)
Mar 2009
-
-$22.63 M(-24.7%)
-$102.49 M(+49.2%)
Dec 2008
-
-$30.07 M(-13.9%)
-$68.70 M(+49.3%)
Sept 2008
-
-$34.94 M(+135.3%)
-$46.01 M(+21.6%)
June 2008
-$37.85 M(-64.1%)
-$14.85 M(-233.1%)
-$37.85 M(-10.6%)
Mar 2008
-
$11.15 M(-251.1%)
-$42.32 M(-38.3%)
Dec 2007
-
-$7.38 M(-72.4%)
-$68.59 M(-16.3%)
Sept 2007
-
-$26.78 M(+38.6%)
-$81.98 M(-22.2%)
June 2007
-$105.42 M(-12.1%)
-$19.31 M(+27.8%)
-$105.42 M(-3.2%)
Mar 2007
-
-$15.12 M(-27.2%)
-$108.89 M(-3.4%)
Dec 2006
-
-$20.77 M(-58.6%)
-$112.70 M(-7.7%)
Sept 2006
-
-$50.21 M(+120.3%)
-$122.08 M(+1.8%)
June 2006
-$119.87 M(+38.1%)
-$22.79 M(+20.5%)
-$119.87 M(+5.3%)
Mar 2006
-
-$18.92 M(-37.3%)
-$113.81 M(-13.5%)
Dec 2005
-
-$30.16 M(-37.2%)
-$131.54 M(-3.1%)
Sept 2005
-
-$48.00 M(+187.0%)
-$135.72 M(+56.4%)
June 2005
-$86.78 M(+29.8%)
-$16.73 M(-54.4%)
-$86.78 M(+6.9%)
Mar 2005
-
-$36.65 M(+6.7%)
-$81.20 M(+20.1%)
Dec 2004
-
-$34.34 M(-3749.3%)
-$67.59 M(+98.7%)
Sept 2004
-
$941.00 K(-108.4%)
-$34.02 M(-49.1%)
June 2004
-$66.84 M(+462.5%)
-$11.15 M(-51.6%)
-$66.84 M(+9.9%)
Mar 2004
-
-$23.04 M(+2888.8%)
-$60.82 M(+26.6%)
Dec 2003
-
-$771.00 K(-97.6%)
-$48.03 M(+13.5%)
Sept 2003
-
-$31.87 M(+520.3%)
-$42.32 M(+256.1%)
June 2003
-$11.88 M(-187.8%)
-$5.14 M(-49.9%)
-$11.88 M(-144.0%)
Mar 2003
-
-$10.26 M(-307.4%)
$27.03 M(-40.8%)
Dec 2002
-
$4.94 M(-444.8%)
$45.62 M(+26.3%)
Sept 2002
-
-$1.43 M(-104.2%)
$36.11 M(+166.8%)
June 2002
$13.54 M(-109.4%)
$33.77 M(+305.1%)
$13.54 M(-110.7%)
Mar 2002
-
$8.34 M(-282.7%)
-$126.56 M(-16.3%)
Dec 2001
-
-$4.56 M(-81.0%)
-$151.21 M(+1.4%)
Sept 2001
-
-$24.01 M(-77.4%)
-$149.10 M(+3.2%)
June 2001
-$144.55 M(+680.3%)
-$106.33 M(+552.0%)
-$144.55 M(+231.8%)
Mar 2001
-
-$16.31 M(+562.4%)
-$43.56 M(+39.0%)
Dec 2000
-
-$2.46 M(-87.3%)
-$31.34 M(-6.1%)
Sept 2000
-
-$19.45 M(+264.2%)
-$33.38 M(+80.2%)
June 2000
-$18.52 M(-25.6%)
-$5.34 M(+30.9%)
-$18.52 M(+6.6%)
Mar 2000
-
-$4.08 M(-9.3%)
-$17.38 M(-19.5%)
Dec 1999
-
-$4.50 M(-2.2%)
-$21.60 M(-15.3%)
Sept 1999
-
-$4.60 M(+9.5%)
-$25.50 M(+2.4%)
June 1999
-$24.90 M(-8400.0%)
-$4.20 M(-49.4%)
-$24.90 M(+21.5%)
Mar 1999
-
-$8.30 M(-1.2%)
-$20.50 M(+107.1%)
Dec 1998
-
-$8.40 M(+110.0%)
-$9.90 M(+57.1%)
Sept 1998
-
-$4.00 M(-2100.0%)
-$6.30 M(-2200.0%)
June 1998
$300.00 K(-105.7%)
$200.00 K(-91.3%)
$300.00 K(-116.7%)
Mar 1998
-
$2.30 M(-147.9%)
-$1.80 M(-70.0%)
Dec 1997
-
-$4.80 M(-284.6%)
-$6.00 M(+233.3%)
Sept 1997
-
$2.60 M(-236.8%)
-$1.80 M(-66.0%)
June 1997
-$5.30 M(-15.9%)
-$1.90 M(0.0%)
-$5.30 M(+55.9%)
Mar 1997
-
-$1.90 M(+216.7%)
-$3.40 M(+126.7%)
Dec 1996
-
-$600.00 K(-33.3%)
-$1.50 M(+66.7%)
Sept 1996
-
-$900.00 K
-$900.00 K
June 1996
-$6.30 M(-71.7%)
-
-
June 1995
-$22.30 M(+4360.0%)
-
-
June 1994
-$500.00 K(+150.0%)
-
-
June 1993
-$200.00 K
-
-

FAQ

  • What is ResMed annual cash flow from investing activities?
  • What is the all time high annual CFI for ResMed?
  • What is ResMed annual CFI year-on-year change?
  • What is ResMed quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for ResMed?
  • What is ResMed quarterly CFI year-on-year change?
  • What is ResMed TTM cash flow from investing activities?
  • What is the all time high TTM CFI for ResMed?
  • What is ResMed TTM CFI year-on-year change?

What is ResMed annual cash flow from investing activities?

The current annual CFI of RMD is -$269.78 M

What is the all time high annual CFI for ResMed?

ResMed all-time high annual cash flow from investing activities is $13.54 M

What is ResMed annual CFI year-on-year change?

Over the past year, RMD annual cash flow from investing activities has changed by +$890.06 M (+76.74%)

What is ResMed quarterly cash flow from investing activities?

The current quarterly CFI of RMD is $2.15 M

What is the all time high quarterly CFI for ResMed?

ResMed all-time high quarterly cash flow from investing activities is $33.77 M

What is ResMed quarterly CFI year-on-year change?

Over the past year, RMD quarterly cash flow from investing activities has changed by +$151.13 M (+101.44%)

What is ResMed TTM cash flow from investing activities?

The current TTM CFI of RMD is -$118.66 M

What is the all time high TTM CFI for ResMed?

ResMed all-time high TTM cash flow from investing activities is $45.62 M

What is ResMed TTM CFI year-on-year change?

Over the past year, RMD TTM cash flow from investing activities has changed by +$1.13 B (+90.51%)